| Novartis Pharma Schweiz AG - Sandimmun Neoral, Trinklösung |
| 52657 | | 01 | | Sandimmun Neoral | | Trinklösung | | L04AD01 | | Ciclosporin | | 16.05.1994 | | |
|
| Composition |
| ciclosporinum 100 mg, ethanolum anhydricum 94.7 mg, propylenglycolum 94.7 mg, interesterified corn oil, macrogolglyceroli hydroxystearas 383.7 mg, E 307, ad solutionem pro 1 ml corresp. ethanolum 12 % V/V. |
| Packungsbestandteile |
| Solution (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Ciclosporine | 100 mg/ml |
| | BAG: Principe actif | Concentr. |
|---|
| Ciclosporine | 100 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| E 307 | | | Ethanol Anhydrate | 94.7 mg/ml | | Interesterified corn Oil | | | Macrogolglyceroli Hydroxystearas | 383.7 mg/ml | | Propylenglycol | 94.7 mg/ml |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 016 | 50 ml | 173.64 | 205.25 | B | LS | Non |
|
